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ABSTRACT The estl mutant was previously identified
because it is defective in telomere maintenance and displays
a senescent phenotype. To see if Estl might be a component
of yeast telomerase, we examined immunoprecipitated Estl.
The yeast telomerase RNA Tlcl specifically coprecipitated
with Estl. Furthermore, the Estl immunoprecipitates con-
tained a telomerase-like activity. As expected for yeast telo-
merase, the activity elongated telomeric primers, it required
dGTP and dTTP but not dATP or dCTP, and it was sensitive
to RNase A. Further evidence suggesting that the activity was
telomerase was obtained from experiments using a TLCI-1
mutant strain, which has a mutant telomerase template
containing dG residues. The activity immunoprecipitated
from TLCI-1 mutant strains incorporated 32P-labeled dCTP,
while activity from TLCI strains did not. Use of different
telomeric primer substrates revealed two distinguishable te-
lomerase-like activities: one was dependent on TLC1, and one
was not. The TLCl-independent activity may be due to a
second yeast telomerase RNA, or it may be some other kind of
activity.
The ends of eukaryotic chromosomes are capped by structures
called telomeres which prevent the ends from being degraded(1, 2). Telomeric DNA consists of repeats of simple sequences,
such as TTAGGG in humans, and TGi-3 in the yeast Saccha-
romyces cerevisiae. Telomeres are maintained by an enzyme
called telomerase, which adds the repeats to the very ends of
the chromosomes, thereby balancing the loss of repeats which
occurs during replication (3-5). Telomerase is a remarkable
enzyme containing both RNA and protein components. The
RNA component contains the template for addition of repeats.
For instance, the Tetrahymena thermophila telomerase RNA
contains the sequence CAACCCCAA, which templates the
addition of TTGGGG repeats (6). The yeast telomerase RNA
Tlcl contains the sequence ACCACACCCACACAC, which
templates the addition of the TG1-3 repeats (7). Since mature
yeast telomeres contain mostly imperfect copies of the tem-
plate (8, 9), copying in yeast must be degenerate and imprecise.
Telomerase activity has been discovered in a number of
organisms, and the telomerase RNA has been cloned in a few
cases (3). Two protein components of telomerase have recently
been identified in Tetrahymena; these show little homology to
other known proteins (10). One possible candidate for a yeast
telomerase component is the Estl (Ever Shorter Telomeres)
protein (11). Yeast cells lacking ESTI suffer telomere short-
ening, and clonal cultures undergo senescence, with most cells
in the culture dying after 80-100 population doublings (11, 12).
MATERIALS AND METHODS
Yeast Media, Strains, and Plasmids. Standard methods
were used for growth and manipulation of yeast (13). For
telomerase assays, yeast were grown in 1% yeast extract/2%
peptone/2% dextrose (YEPD). All strains were isogenic with
W303a [MATa ade2-1 trpl-1 leu2-3,112 his3-11,15 ura3-1
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canl-100 ssdl-d (psi+)] (14). The genomic copy of EST1 was
tagged at the 5' end with a triplicated hemagglutinin tag (15)
by a recombinational method (16). The TLCl-1 mutant strain
was created by transformation of cells with plasmid pRS306-
TLC1-1 (Hae III). The tlcl deletion/disruption strain was
created by transformation with the Xho I fragment of plasmid
pBlue61::LEU2. These plasmids were kindly provided by M.
Singer and D. Gottschling (7). The estl disruption was made
by inserting URA3 after the start codon by a recombinational
method (17). This disruption allele had an Est- phenotype, but
we have no evidence that it is a null allele.
Yeast Extracts and Immunoprecipitation. Yeast extracts
were made by beating yeast cells with zirconia beads (0.5-mm
diameter; Biospec Products) and buffer A [50 mM Tris-
acetate, pH 7.6/50 mM potassium acetate/0.2 mM EDTA/0.2
mM EGTA/5% (vol/vol) glycerol/4 mM dithiothreitol/100
tLg of aprotinin per ml/4 ,tg of pepstatin per ml/4 ,ag of
leupeptin per ml/100 Atg of phenylmethylsulfonyl fluoride per
ml/200 ,tg of soybean trypsin inhibitor per ml/100 tug of
7-amino-l-chloro-3-tosylamido-2-heptanone (TLCK) per
ml/10 jug of L-l-tosylamido-2-phenylethyl chloromethyl ke-
tone (TPCK) per ml/10 units of RNase inhibitor per ml] for
50 sec in a mini-bead beater (Biospec Products) at medium-
high speed. The extract was clarified by two centrifugation
steps at 16,000 x g for 10 min and 15 min, respectively. The
protein concentration was determined by the Bradford assay,
with reagent from Bio-Rad.
For immunoprecipitation for telomerase assays, 0.4 tul of
ascites fluid from the 12CA5 cell line was added for each 5 mg
of protein in the sample of extract. The solution was incubated
on ice for 1.5 h. Washed protein A beads (Pierce) were added(5 ,l of beads per 5 mg of protein), and the mixture was
incubated with gentle agitation for 2 h at 4°C. The protein A
beads were collected by a very brief, very gentle centrifugation(1 sec, <500 x g) and washed four times with buffer B [25 mM
Tris-acetate, pH 8.2/50 mM potassium acetate/I mM
EGTA/1 mM MgCl2/10% (vol/vol) glycerol/2 mM dithio-
threitol] supplemented with 5 units of RNase inhibitor per ml.
Centrifugation steps were brief (1 sec or less) and used minimal
g forces; otherwise, various activities were precipitated non-
specifically. Finally, the washed beads were resuspended. For
every 5 mg of protein in the original sample of extract, 20 tul
of buffer B plus 0.1 units of RNase inhibitor was added.
Coimmunoprecipitation of Tlcl with Estl was similar, but a
high-salt lysis buffer was used (50mM Tris-HCl, pH 7.5/250mM
NaCl/50 mM NaF/5 mM EDTA/0.1% Nonidet P-40/5 mM
dithiothreitol. Cell extracts were incubated with antibody for 20
min. Extract containing 10 mg of protein was immunoprecipi-
tated by using 0.6 tuL of 12CA5 ascites fluid, and one-eighth of the
immunoprecipitate was loaded on the gel. Epitope peptide
competition experiments used 0.6 tul of 12CA5 ascites fluid, 100jug of competitor peptide (YPYDVPDYA), and extract contain-
ing 10 mg of protein. In Fig. 1, lanes 1 and 4 contain the total RNA
from extract containing 12.5 tug of protein-i.e., they represent
about 1% as much extract as the lanes containing immunopre-
cipitates.
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Estl protein could not be seen by direct Western analysis
when 50 jig of total yeast protein was loaded on the gel.
However, Estl could be seen on a Western blot after it was
immunoprecipitated from extract containing 4 mg of total
yeast protein (16).
Telomerase Assays. Telomerase assays were performed in a
volume of 40 ,ul in buffer B without glycerol with 20 pL1 of
immunoprecipitate (corresponding to 5 mg of initial protein).
Further additions were 1 ,uM dGTP (ofwhich 0.25-0.5 ,IM was[a-32P]dGTP; 3000 Ci/mmol; 1 Ci = 37 GBq, 100 ,M dTTP,
1 mM spermidine, and 2 ,iM substrate oligonucleotide. The
reaction was incubated at 30°C. After 2 h., 160 jul of water was
added, and the mixture was extracted with 200 jul of phenol/
chloroform/isoamyl alcohol (25:24:1). Ammonium acetate
and MgCl2 were added to the aqueous phase to concentrations
of 2.5 M and 10 mM, respectively, 10 jug of yeast tRNA was
added, and nucleic acids were precipitated with two volumes
of cold ethanol. The DNA was pelleted by centrifugation,
washed twice with cold 70% (vol/vol) ethanol, dried, and
loaded onto a 12% acrylamide/7M urea sequencing gel. Gels
were dried and placed on Fuji PhosphorImager screens for
about two days. RNase A sensitivity was shown by incubating
the immunoprecipitates with 10-100 ng of heat-treated RNase
A for 20 min at room temperature before addition of other
assay components. Telomerase activity was not destroyed if a
mixture of 100 ng of RNase A and 160 units of human placental
RNase inhibitor (Boehringer Mannheim) were added to the
immunoprecipitate. Oxidized, inactive RNase A was obtained
from Sigma.
RESULTS
To see if Estl might be a component of telomerase, we tagged
Estl at its N terminus with three tandem copies of the
hemagglutinin epitope. The tagged gene complemented an
estl mutant, although the phenotype was not completely wild
type. We were able to detect the tagged Estl on immunoblots,
but only after it had been concentrated by immunoprecipita-
tion (data not shown).
When the tagged Estl protein was immunoprecipitated, the
telomerase RNA was coprecipitated (Fig. 1). Little or no
telomerase RNA was precipitated from an untagged strain by
the same antibodies, and addition of competing epitope pep-
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tide blocked coimmunoprecipitation, showing that the associ-
ation of Tlcl with Estl was specific. Only 1-5% of the Tlcl
RNA in the extracts could be coprecipitated with Estl. Since
we cannot see Estl by direct Western analysis (Materials and
Methods), we do not know how efficiently Estl is immunopre-
cipitated. Therefore, we do not know whether the low yield of
Tlcl is because only a small portion of the Tlcl in the cell is
associated with Estl or because Estl is inefficiently immuno-
precipitated.
A telomerase-like activity was found in the Estl immuno-
precipitates. When incubated with a suitable substrate oligo-
nucleotide, dTTP, [a-32P]dGTP, and an appropriate buffer,
about 20 nt were added to the substrate oligonucleotide (Fig.
2). Optimal activity required the simultaneous presence of
both dTTP and dGTP (Fig. 3) but not dCTP or dATP.
Tetrahymena and human telomerase give a distinctive, phased
pattern of strong and weak bands; no such pattern was seen
here. However, yeast telomeres contain degenerate copies of
the telomerase template, perhaps suggesting that the enzyme
slips frequently, so a phased pattern is not necessarily ex-
pected.
As expected for telomerase, the activity was destroyed by as
little as 10 ng of RNase A (Fig. 2). An inactive, oxidized form
of RNase A failed to inhibit the telomerase-like activity (data
not shown). Furthermore, a mixture of RNase A and RNase
inhibitor failed to inhibit the telomerase-like activity (data not
shown). Thus, the telomerase-like activity was sensitive to
ribonuclease.
We considered the possibility that some reverse tran-
scriptase might be transcribing RNA molecules fortuitously
present in the immunoprecipitates. To test this, we treated an
immunoprecipitate with RNase A, then added RNase inhib-
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FIG. 1. Tlcl coprecipitates with Estl. Northern blot of RNA from
an untagged yeast strain (lanes 1, 2, and 3) or from a strain carrying
tagged Estl (lanes 4, 5, and 6). Lanes 1 and 4 show total RNA from
the two strains. Lanes 2 and 5 show the RNAs in the 12CA5
immunoprecipitates (I.P.s). Lanes 3 and 6 show the RNAs in the
immunoprecipitates in an experiment where a synthetic epitope
peptide was added to block the antibody. The blot was hybridized to
a TLCI probe and to anACTI (actin) probe as a loading control. Lanes
2, 3, 5, and 6 (immunoprecipitates) represent about 100 times more
extract than lanes 1 and 4 (total RNA) (see Materials and Methods).
FIG. 2. Elongation of oligonucleotides by the telomerase-like
activity. Telomerase assays were done on a variety of oligonucleotides
by using 12CA5 immunoprecipitates from a tagged Estl strain.
Reactions contained dTTP and [32P]dGTP. TELPT, TELPG,
MORIN, etc. are the names of substrate oligonucleotides; the se-
quences are presented in Table 1. Lanes 4, 6, and 7 were controls. Lane
4, no added oligonucleotide (-oligo); lane 6, immunoprecipitate
treated with 10 ng of RNase A before telomerase assay with oligo-
nucleotide TELPT (+RNase); and lane 7, extract from an untagged
strain assayed with oligonucleotide TELPT (untagged). Lane I shows
end-labeled oligonucleotide TELPG, and lane 2 shows end-labeled
restriction fragments of about 75 bp, as size markers.
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FIG. 3. Optimal telomerase-like activity requires both dGTP and
dTTP. Telomerase assays were carried out with immunoprecipitates
from a tagged Estl strain (lanes 1 and 2) or an untagged strain (lane
3) by using TELPT as the substrate oligonucleotide. In lane 1[32P]dGTP was added but not dTTP (similar results were obtained
with [32P]dTTP alone; data not shown). In lanes 2 and 3, [32P]dGTP
and unlabeled dTTP were added.
itor, and finally added back 0.1, 1, or 10 ,tg of total yeast RNA.
Despite the readdition of RNA, no telomerase-like activity was
detected (data not shown). [Reconstitution of bona fide te-
lomerase would not be expected because the amount of Tlcl
RNA in the total yeast RNA was very small. Reconstitution of
Tetrahymena telomerase is inefficient even with semipurified
proteins and large amounts of pure telomerase RNA (18).]
Thus, the RNase A sensitivity was not due to a nonspecific
requirement for RNA.
The activity was quite specific for oligonucleotides mimick-
ing the G-rich strand of yeast telomeres (Table 1). Several
oligonucleotides modeled on the yeast telomere were assayed,
and all were elongated. In contrast, oligonucleotides modeled
on the human telomere or on the C-rich strand of the yeast
telomere were not elongated. Several other test oligonucleo-
tides of unrelated sequence were also assayed. Some of these
incorporated a few nucleotides, but none gave the 20-nt ladder
typical of the yeast telomeric primers.
To provide further evidence that the activity in the Estl
immunoprecipitates was yeast telomerase, we took advantage
of the TLCI-1 mutation (7). The template region of wild-type
Tlcl RNA contains no G residues, but in the mutant Tlcl-1
RNA, a C residue and the adjacent A residue have been
changed to G residues. Since the mutant telomerase has G
residues in the template, it now incorporates dCTP in vivo (7).
We compared Estl immunoprecipitates from a TLC1 strain
and a TLCI-1 mutant strain. When given dTTP, dCTP, and[a-32P]dGTP, the activities from the two strains used the
[a-32P]dGTP equally well. However, when given dTTP, dGTP,
and [a-32P]dCTP, the activity precipitated from TLC1 strains
incorporated very little or no [a-32P]dCTP. Activities precip-
itated from the TLCI-1 strains were variable: in some cases
(Fig. 4), there was very good incorporation of [a-32P]dCTP,
while in other cases (data not shown) the incorporation was not
better than for the TLC1 experiment.
One possible explanation for the variability of [a-32P]dCTP
incorporation with extracts from the TLCI-1 strain is that only
a part of the template region is used, and the mutant region is
not always copied. We tested this possibility using oligonucle-
otide TELPGGG, which ends in GGG (Table 1) (an experi-
ment suggested by D. Gottschling). This oligonucleotide can
align at only one place along the template, immediately
adjacent to the mutant nucleotides. When this oligonucleotide
was used in telomerase reactions, incorporation of[a-32P]dCTP was robust and repeatable with extracts from the
TLCI-1 strain, but there was little or no incorporation with
extracts from the TLC1 strain (Fig. 5). This shows that the
activity seen with oligonucleotide TELPGGG was being tem-
plated by TLCI-1.
We also assayed activity in Estl immunoprecipitates from a
tlcl deletion strain. The tlcl deletion strain had a senescent
phenotype. Southern analysis showed that no TLC1 gene was
present, and Northern analysis showed that no Tlcl RNA was
present (data not shown). When oligonucleotide TELPGGG
was used as the substrate, the tlcl extracts showed no telo-
merase activity, as expected (Fig. 6). However, surprisingly,
some telomerase-like activity was seen in tlcl extracts when
oligonucleotide TELPT was used (Fig. 6). The activity seen
with oligonucleotide TELPT was still sensitive to RNase A(Fig. 6). Thus, it appears that there are at least two activities
in the Estl immunoprecipitates: one which can elongate
oligonucleotide TELPGGG (and probably TELPT as well)
and is TLC1 dependent, and one which cannot elongate
TELPGGG and is not TLC1 dependent. Both these activities
require dGTP and dTTP but not dATP or dCTP (Fig. 3 and
data not shown), and both are sensitive to RNase A.
Immunoprecipitates of extracts from untagged strains often
showed weak activity on oligonucleotide TELPT (see, for
example, Figs. 3 and 6). Immunoprecipitates from yeast ex-
tracts usually contain significant amounts of nonspecific ma-
terial, so some nonspecifically associated activity is not unex-
pected. We asked whether the nonspecifically precipitated
activity was dependent on the presence of an EST1 gene. A
strain bearing an estl::URA3 disruption was tested, and small
Table 1. Substrate oligonucleotides
Telomerase
Oligonucleotide Sequence activity
TELPT (28 nt) GTGTGTGGGTGTGTGTGTGGGTGTGTGT + + +
TELPG (27 nt) GTGTGTGGGTGTGTGTGTGGGTGTGTG + + +
TELPGGG (28 nt) TGTGTGTGTGTGTGGGTGTGTGTGTGGG + + +
HTELS3 (18 nt) TTAGGGTTAGGGTTAGGG
HTELS4 (24 nt) GGGTTAGGGTTAGGGTTAGGGTTA
MORIN (25 nt) GCTTGCCAATCCGTCGAGCAGAGTT +
HTELREP1 (26 nt) CACACCCACACACCACACCCACACAC
TELPT, TELPG, and TELPGGG mimic the yeast telomeric G-rich strand, while HTELS3 and
HTELS4 mimic the human telomeric G-rich strand. MORIN is a nontelomeric oligonucleotide which
nevertheless serves as a good substrate for human telomerase (19). HTELREP1 mimics the yeast
telomeric C-rich strand. +++ indicates robust addition of 10 or more nucleotides to the substrate
oligonucleotide in telomerase reactions. + indicates the addition of a few nucleotides.
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FIG. 4. The TLC-1I mutation allows incorporation of[a-32P]dCTP. Immunoprecipitates were prepared from an untagged
wild-type strain (lanes 1 and 4), from an Estl-tagged strain with
wild-type TLC1 (lanes 2 and 5), and from an Estl-tagged strain with
mutant TLCI-1 (lanes 3 and 6). Telomerase assays were carried out
with TELPT as a substrate oligo, either in the presence of[a-32P]dGTP plus unlabeled dTTP (lanes 1, 2, and 3) or in the
presence of [a-32P]dCTP plus unlabeled dGTP and dTTP (lanes 4, 5,
and 6).
amounts of telomerase-like, RNase A-sensitive activity were
found in immunoprecipitates (Fig. 6). The activity was quan-
titatively comparable with the trace activity in immunopre-
cipitates from an untagged EST1 strain. Thus, this activity does
not depend on Estl.
Little or no nonspecifically precipitated activity was seen
when oligonucleotide TELPGGG was used as substrate (Fig.6). Again, this argues that there are two different telomerase-
like activities. Because the TELPGGG assay cannot be donein the absence of tagged Estl, we cannot tell whether this
TELPGGG activity is present in an estl mutant.
DISCUSSION
Cells lacking EST1 have similar or identical phenotypes to cells
lacking TLC1 (7, 11). Both kinds of mutants exhibit shortening
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FIG. 5. TLCI-I allows incorporation of [a-32P]dCTP. Lanes 1, 2,
and 3 are as in Fig. 4, but with TELPGGG as substrate. Lane 4 is
end-labeled TELPGGG. Lanes 5, 6, and 7 are as lanes 4, 5, and 6 in
Fig. 4, but with TELPGGG as substrate.
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FIG. 6. Telomerase-like activities in tlcl and estl strains. Telo-
merase assays were done with [32P]dGTP and unlabeled TTP by using
immunoprecipitates from the indicated strains and oligonucleotide
TELPT (lanes 1-6) or TELPGGG (lanes 7-10). RNase A (10 ng) was
added to the reaction mixtures shown in lanes 4, 6, and 9. The arrow
indicates the position of end-labeled TELPGGG.
telomeres, and both senesce-i.e., have a limited replicative
capacity. This is consistent with the idea that Estl is important
for telomerase function in vivo. We now show that Estl is
physically associated with Tlcl and with a telomerase-like
activity. Evidence that the activity is telomerase includes the
nucleotide specificity, the primer specificity, and the RNase A
sensitivity, but the strongest evidence is that when the template
region of TLC1 is changed to include G residues, the activity
will begin to incorporate dCTP residues.
Curiously, we seem to have found two activities. One acts on
the TELPGGG oligonucleotide (and probably others), while
the second acts on TELPT but not on TELPGGG. The
TELPGGG activity is absent in a tlcl strain and is not
nonspecifically immunoprecipitated in an untagged EST1
strain. In contrast, TELPT activity is present even in a tlcl null
strain, and some is nonspecifically immunoprecipitated from
an estl extract or an untagged EST1 extract. We are confident
that the activity seen on oligonucleotide TELPGGG is a yeast
telomerase because it is absent in a tlcl null strain, and it
incorporates dCTP residues in the TLCI-1 mutant. However,
we are uncertain of the nature of the TELPT activity seen in
a tlcl strain. It is telomerase-like in that it is sensitive to RNase
A, and it has the correct nucleotide and substrate specificity,
but perhaps other kinds of activities could also have these
characteristics. If this activity is indeed a telomerase, then the
fact that it persists in a tlcl deletion strain suggests that there
may be a second telomerase RNA. Until a second such RNA
is found and appropriate mutations made and tested, we will
not be sure whether the TLCl-independent activity seen with
oligonucleotide TELPT is a telomerase or some other kind of
activity.
We note that neither TLC1 nor EST1 is an essential gene in
the usual sense; rather, mutants "senesce" over many gener-
ations. This has been explained by saying that telomeric
sequences are lost only very gradually from the end of the
chromosome, presumably because of the end-replication prob-
lem (20, 21). The loss is surprisingly slow: Lundblad and
2820 Biochemistry: Steiner et al.
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Szostak (11) estimated that an estl strain lost about 100 bp of
telomeric sequence per 25 generations. This rate of 4 bp per
generation implies that RNA primers of 8 bp or less are
sufficient for DNA replication. Furthermore, "survivors" oc-
cur in estl populations, which are due to amplification of
subtelomeric repeat sequences, and these can be grown indef-
initely (12). These survivors apparently still have some TGi-3
at their chromosome ends even after hundreds of generations
in the absence of estl (12). It is possible that the slow
senescence in estl and in tlcl mutants and the continued
presence of TGI_3 repeats after many generations of growth in
estl survivors is due to the continued presence of some kind
of telomerase activity. A strain completely lacking telomerase
might die more rapidly.
Our finding of two telomerase-like activities may help
explain other recent results. Yeast telomerase activity has
recently been detected by other investigators (22-24). In one
study, an oligonucleotide ending in GGG was used as sub-
strate, and activity was absent when tlcl strains were used (22).
In a second study, an oligonucleotide ending in GTG was used,
and some telomerase-like activity was present in tlcl null
strains (23). Our results with oligonucleotides TELPGGG and
TELPT suggest that these apparently conflicting results may
be due to the different oligonucleotides used as substrates.
These two studies also differed in that one found activity in estl
strains (22), while the other did not (23). We find that the
TLCl-independent activity is present in estl strains. However,
while the TLCl-dependent activity is clearly associated with
Estl, we have no information on whether it is dependent on
ESTI because it is not nonspecifically precipitated, and so we
cannot assay for it in an estl mutant.
Five percent or less of the Tlcl RNA could be coimmuno-
precipitated with Estl. Although there are other interpreta-
tions, this may mean that only a fraction of the cell's telomerase
is associated with Estl. Estl may not be a catalytic subunit, but
rather an accessory protein, perhaps responsible for targeting
the complex to telomeres or for regulation of the complex.
The recent identification of the yeast telomerase RNA (7),
and now the identification of yeast telomerase activity and an
associated protein (refs. 22-24 and this work), will allow rapid
advances in the study of this enzyme by using the molecular and
genetic tools available in yeast.
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